Physician profile
Ellen Jacobsen
NPI 1821092891
$810.92
in general payments reported to CMS, 2019-2025
10 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $39.57 · 2022: $63.93 · 2023: $85.97 · 2024: $267 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398 · Education: $61.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.38 |
| Education | $61.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $336.60 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $102.79 | 2022-2024 | |
| Galderma Laboratories, L.P. | $80.63 | 2019 | |
| Celgene Corporation | $65.10 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $61.85 | 2024 | Sotyktu |
| Almirall LLC | $55.43 | 2023 | Seysara |
| Sun Pharmaceutical Industries INC. | $39.57 | 2020 | |
| Biofrontera INC. | $37.25 | 2019-2022 | |
| Abbvie INC. | $17.96 | 2024 | |
| Revance Therapeutics, INC. | $13.74 | 2024 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Jacobsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.